RMB Capital Management LLC decreased its holdings in Danaher Co. (NYSE:DHR) by 0.4% in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 256,861 shares of the conglomerate’s stock after selling 1,118 shares during the quarter. Danaher accounts for approximately 1.7% of RMB Capital Management LLC’s holdings, making the stock its 2nd biggest holding. RMB Capital Management LLC’s holdings in Danaher were worth $35,552,000 at the end of the most recent quarter.
Several other hedge funds have also made changes to their positions in the company. Solstein Capital LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $422,000. Bamco Inc. NY increased its position in shares of Danaher by 8.1% during the 4th quarter. Bamco Inc. NY now owns 2,194 shares of the conglomerate’s stock worth $337,000 after purchasing an additional 165 shares in the last quarter. BerganKDV Wealth Management LLC increased its position in shares of Danaher by 474.5% during the 4th quarter. BerganKDV Wealth Management LLC now owns 2,752 shares of the conglomerate’s stock worth $422,000 after purchasing an additional 2,273 shares in the last quarter. Rodgers Brothers Inc. acquired a new stake in shares of Danaher during the 4th quarter worth about $203,000. Finally, Savior LLC acquired a new stake in shares of Danaher during the 4th quarter worth about $32,000. Institutional investors own 77.88% of the company’s stock.
In related news, SVP Daniel Raskas sold 37,082 shares of Danaher stock in a transaction that occurred on Friday, May 8th. The shares were sold at an average price of $164.09, for a total transaction of $6,084,785.38. Following the transaction, the senior vice president now owns 19,723 shares of the company’s stock, valued at approximately $3,236,347.07. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CAO Robert S. Lutz sold 33,892 shares of Danaher stock in a transaction that occurred on Friday, May 8th. The stock was sold at an average price of $161.68, for a total transaction of $5,479,658.56. Following the transaction, the chief accounting officer now directly owns 18,950 shares in the company, valued at approximately $3,063,836. The disclosure for this sale can be found here. Insiders have sold a total of 70,974 shares of company stock worth $11,564,444 in the last three months. 11.70% of the stock is owned by insiders.
DHR has been the subject of a number of recent analyst reports. Citigroup increased their target price on shares of Danaher from $180.00 to $190.00 and gave the stock a “buy” rating in a research report on Friday, May 8th. Royal Bank of Canada increased their target price on shares of Danaher from $159.00 to $173.00 and gave the stock an “outperform” rating in a research report on Monday, May 11th. Cowen reissued a “buy” rating and set a $170.00 price objective on shares of Danaher in a report on Monday, February 3rd. Wolfe Research lowered shares of Danaher from an “outperform” rating to a “market perform” rating and set a $154.00 price objective on the stock. in a report on Thursday, April 2nd. Finally, Bank of America increased their price objective on shares of Danaher from $160.00 to $181.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Six research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $168.69.
Shares of NYSE DHR traded up $0.60 during mid-day trading on Friday, hitting $158.26. The company’s stock had a trading volume of 1,483,268 shares, compared to its average volume of 3,639,653. The stock has a market cap of $109.97 billion, a price-to-earnings ratio of 35.97, a price-to-earnings-growth ratio of 3.56 and a beta of 0.93. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.32 and a quick ratio of 1.01. Danaher Co. has a one year low of $119.60 and a one year high of $170.64. The company’s fifty day simple moving average is $155.43 and its 200-day simple moving average is $151.19.
Danaher (NYSE:DHR) last issued its earnings results on Wednesday, May 6th. The conglomerate reported $1.05 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.00 by $0.05. The company had revenue of $4.34 billion for the quarter, compared to analyst estimates of $4.32 billion. Danaher had a net margin of 16.85% and a return on equity of 11.52%. The company’s revenue for the quarter was up 2.9% on a year-over-year basis. During the same quarter last year, the firm earned $1.07 EPS. On average, sell-side analysts predict that Danaher Co. will post 4.88 EPS for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Friday, June 26th will be paid a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a yield of 0.45%. The ex-dividend date is Thursday, June 25th. Danaher’s payout ratio is 16.29%.
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments; Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.
Recommended Story: Why are percentage gainers important?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.